Clinical trial
Age-Related Eye Disease Study 2 (AREDS2)
NCT00345176 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00345176 |
|---|---|
| Title | Age-Related Eye Disease Study 2 (AREDS2) |
| Official title | Age-Related Eye Disease Study 2 (AREDS2): A Multi-center, Randomized Trial of Lutein, Zeaxanthin and Omega-3 Long-Chain Polyunsaturated Fatty Acids (Docosahexaenoic Acid [DHA] and Eicosapentaenoic Acid [EPA]) in Age-Related Macular Degeneration |
| Acronym | AREDS2 |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH Office of Dietary Supplements (ODS) National Center for Complementary and Integrative Health (NCCIH) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Age-related Macular Degeneration, Cataract |
| Intervention type | Dietary Supplement, Drug |
| Interventions | Lutein/zeaxanthin, DHA/EPA, Lutein/zeaxanthin and DHA/EPA |
| Enrollment | 4,203 |
| Start date | Sep 1, 2006 |
| Primary completion | Oct 1, 2012 |
| Completion | Oct 1, 2012 |
| First posted | Jun 27, 2006 |
| Last update posted | May 5, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: